AZD7687

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
We have developed a novel mechanistic pharmacokinetic-pharmacodynamic (PK/PD) model to describe the time course of plasma… Expand
  • table 1
Is this relevant?
2015
2015
Diacylglycerol O-acyltransferase 1 (DGAT1) plays an important role in synthesizing lipids, and inhibitors of DGAT1 have been… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
AIM Inhibition of diacylglycerol acyltransferase 1 (DGAT1) is a potential treatment modality for patients with type 2 diabetes… Expand
Is this relevant?
2013
2013
AIMS Inhibition of diacylglycerol acyltransferase 1 (DGAT1), which catalyses the final step in triacylglycerol (TAG) assembly, is… Expand
Is this relevant?
2013
2013
A one-week phase 1 trial with the DGAT1 inhibitor AZD7687 : lipid handling, hormone secretion and adverse effects in the gut 
Is this relevant?
2012
2012
A new series of pyrazinecarboxamide DGAT1 inhibitors was designed to address the need for a candidate drug with good potency… Expand
  • table 1
  • table 3
  • table 4
  • table 5
  • table 6
Is this relevant?